[Extraneural metastases of gliomas (author's transl)].

M. Tamura,J. Kawafuchi,A. Fukamachi,T. Wakao

Neurologia medico-chirurgica

Abstract:

What problem does this paper attempt to address?

An atlas of substrate specificities for the human serine/threonine kinome

Jared L. Johnson,Tomer M. Yaron,Emily M. Huntsman,Alexander Kerelsky,Junho Song,Amit Regev,Ting-Yu Lin,Katarina Liberatore,Daniel M. Cizin,Benjamin M. Cohen,Neil Vasan,Yilun Ma,Konstantin Krismer,Jaylissa Torres Robles,Bert van de Kooij,Anne E. van Vlimmeren,Nicole Andrée-Busch,Norbert F. Käufer,Maxim V. Dorovkov,Alexey G. Ryazanov,Yuichiro Takagi,Edward R. Kastenhuber,Marcus D. Goncalves,Benjamin D. Hopkins,Olivier Elemento,Dylan J. Taatjes,Alexandre Maucuer,Akio Yamashita,Alexei Degterev,Mohamed Uduman,Jingyi Lu,Sean D. Landry,Bin Zhang,Ian Cossentino,Rune Linding,John Blenis,Peter V. Hornbeck,Benjamin E. Turk,Michael B. Yaffe,Lewis C. Cantley

DOI: https://doi.org/10.1038/s41586-022-05575-3

IF: 64.8

2023-01-12

Nature

Abstract:Protein phosphorylation is one of the most widespread post-translational modifications in biology 1,2 . With advances in mass-spectrometry-based phosphoproteomics, 90,000 sites of serine and threonine phosphorylation have so far been identified, and several thousand have been associated with human diseases and biological processes 3,4 . For the vast majority of phosphorylation events, it is not yet known which of the more than 300 protein serine/threonine (Ser/Thr) kinases encoded in the human genome are responsible 3 . Here we used synthetic peptide libraries to profile the substrate sequence specificity of 303 Ser/Thr kinases, comprising more than 84% of those predicted to be active in humans. Viewed in its entirety, the substrate specificity of the kinome was substantially more diverse than expected and was driven extensively by negative selectivity. We used our kinome-wide dataset to computationally annotate and identify the kinases capable of phosphorylating every reported phosphorylation site in the human Ser/Thr phosphoproteome. For the small minority of phosphosites for which the putative protein kinases involved have been previously reported, our predictions were in excellent agreement. When this approach was applied to examine the signalling response of tissues and cell lines to hormones, growth factors, targeted inhibitors and environmental or genetic perturbations, it revealed unexpected insights into pathway complexity and compensation. Overall, these studies reveal the intrinsic substrate specificity of the human Ser/Thr kinome, illuminate cellular signalling responses and provide a resource to link phosphorylation events to biological pathways.

multidisciplinary sciences
Switching of the Substrate Specificity of Protein Tyrosine Phosphatase N12 by Cyclin‐dependent Kinase 2 Phosphorylation Orchestrating 2 Oncogenic Pathways

Hui Li,Duxiao Yang,Shanglei Ning,Yinghui Xu,Fan Yang,Rusha Yin,Taihu Feng,Shouqing Han,Lu Guo,Pengju Zhang,Wenjie Qu,Renbo Guo,Chen Song,Peng Xiao,Chengjun Zhou,Zhigang Xu,Jin-Peng Sun,Xiao Yu

DOI: https://doi.org/10.1096/fj.201700418r

2017-01-01

Abstract:The protein tyrosine phosphatase nonreceptor type 12 (PTPN12) is a multifunctional protein and has elicited much research attention because its decreased protein level has been associated with poor prognosis of several types of cancers. Recently, we have solved the crystal structure of the phosphatase domain of PTPN12, which disclosed a specific PTPN12-insert-loop harboring a cyclin-dependent kinase 2 (CDK2) phosphorylation site. However, the functional significance of this phosphorylation is undefined. In the present study, we found that S19 site phosphorylation of PTPN12 by CDK2 discharged its antitumor activity by down-regulation of its inhibitory role in cell migration, but not affecting its other regulatory functions. Phosphorylation of PTPN12 at the S19 site changed its substrate interface, and by doing so, selectively decreased its activity toward the human epidermal growth factor receptor 2 (HER2)- pY1196 site, but not other HER2 phosphorylation sites or other known PTPN12 substrates. A further in-depth mechanism study revealed that the phosphorylation of PTPN12 by CDK2 impaired recruitment of the serine/threonine-protein kinase 1 (PAK1) to HER2, resulted in the blockade of the HER2-pY1196-PAK1-T423 signaling pathway, thus increased tumor cell motility. Taken together, our results identified a new phosphorylation-based substrate recognition mechanism of PTPN12 by CDK2, which orchestrated signaling crosstalk between the oncogenic CDK2 and HER2 pathways. The newly identified governing mechanism of the substrate selectivity of a particular phosphatase was previously unappreciated and exemplifies how a phospho-network is precisely controlled in different cellular contexts.-Li, H., Yang, D., Ning, S., Xu, Y., Yang, F., Yin, R., Feng, T., Han, S., Guo, L., Zhang, P., Qu, W., Guo, R., Song, C., Xiao, P., Zhou, C., Xu, Z., Sun, J.-P., Yu, X. Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways.
High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display

Allyson Li,Rashmi Voleti,Minhee Lee,Dejan Gagoski,Neel H Shah

DOI: https://doi.org/10.7554/eLife.82345

IF: 7.7

2023-03-16

eLife

Abstract:Tyrosine kinases and SH2 (phosphotyrosine recognition) domains have binding specificities that depend on the amino acid sequence surrounding the target (phospho)tyrosine residue. Although the preferred recognition motifs of many kinases and SH2 domains are known, we lack a quantitative description of sequence specificity that could guide predictions about signaling pathways or be used to design sequences for biomedical applications. Here, we present a platform that combines genetically encoded peptide libraries and deep sequencing to profile sequence recognition by tyrosine kinases and SH2 domains. We screened several tyrosine kinases against a million-peptide random library and used the resulting profiles to design high-activity sequences. We also screened several kinases against a library containing thousands of human proteome-derived peptides and their naturally-occurring variants. These screens recapitulated independently measured phosphorylation rates and revealed hundreds of phosphosite-proximal mutations that impact phosphosite recognition by tyrosine kinases. We extended this platform to the analysis of SH2 domains and showed that screens could predict relative binding affinities. Finally, we expanded our method to assess the impact of non-canonical and post-translationally modified amino acids on sequence recognition. This specificity profiling platform will shed new light on phosphotyrosine signaling and could readily be adapted to other protein modification/recognition domains.
Site-specific Proteasome Phosphorylation Controls Cell Proliferation and Tumorigenesis

Xing Guo,Xiaorong Wang,Zhiping Wang,Sourav Banerjee,Jing Yang,Lan Huang,Jack E. Dixon

DOI: https://doi.org/10.1038/ncb3289

IF: 21.3

2015-01-01

Nature Cell Biology

Abstract:Despite the fundamental importance of proteasomal degradation in cells, little is known about whether and how the 26S proteasome itself is regulated in coordination with various physiological processes. Here we show that the proteasome is dynamically phosphorylated during the cell cycle at Thr 25 of the 19S subunit Rpt3. CRISPR/Cas9-mediated genome editing, RNA interference and biochemical studies demonstrate that blocking Rpt3-Thr25 phosphorylation markedly impairs proteasome activity and impedes cell proliferation. Through a kinome-wide screen, we have identified dual-specificity tyrosine-regulated kinase 2 (DYRK2) as the primary kinase that phosphorylates Rpt3-Thr25, leading to enhanced substrate translocation and degradation. Importantly, loss of the single phosphorylation of Rpt3-Thr25 or knockout of DYRK2 significantly inhibits tumour formation by proteasome-addicted human breast cancer cells in mice. These findings define an important mechanism for proteasome regulation and demonstrate the biological significance of proteasome phosphorylation in regulating cell proliferation and tumorigenesis.
One-Step SH2 Superbinder-Based Approach for Sensitive Analysis of Tyrosine Phosphoproteome.

Yating Yao,Yan Wang,Shujuan Wang,Xiaoyan Liu,Zhen Liu,Yanan Li,Zheng Fang,Jiawei Mao,Yong Zheng,Mingliang Ye

DOI: https://doi.org/10.1021/acs.jproteome.9b00045

2019-01-01

Journal of Proteome Research

Abstract:Tyrosine phosphorylation plays a major role in regulating cell signaling pathways governing diverse biological functions such as proliferation and differentiation. Systemically mapping phosphotyrosine (pTyr) sites is the key to understanding molecular mechanisms underlining pTyr-dependent signaling. Although mass spectrometry-based technologies have been widely used for pTyr site profiling and quantification, their applications are often hindered by the poor efficiency in current multistep enrichment procedures for inherently low abundance pTyr peptides, especially under physiological conditions. Taking advantage of the sequence-independent high affinity of SH2 superbinder toward pTyr residues, we have developed a simplified one-step pTyr peptide enrichment method that uses immobilized SH2 superbinder for unbiased and robust enrichment of endogenous pTyr peptides from biological samples. By eliminating the prerequisite global phosphopeptide enrichment step in our previously developed two-step method, we minimized sample loss and improved peptide capture efficiency. Applying this method to Jurkat cells at resting state, where the tyrosine phosphorylation level is low, both the number of identified pTyr peptides and sites are increased by three folds compared to the two-step method. Specifically, we were able to identify 511 nonredundant pTyr peptides, corresponding to 403 high confidence pTyr sites, from Jurkat cells with high level technical reproducibility (Pearson's correlation coefficient as high as 0.94). Further applying this method to two human breast cancer cell lines, BT474 and HCC1954, before and after EGF stimulation, we demonstrated that this approach could be a powerful tool for illustrating pTyr-dependent signaling network controlling cellular behaviors such as drug resistance.
Metriphonate and organophosphate poisoning.

V. P. Jamnadas,J. Thomas

1979-06-01

Central African Journal of Medicine

Abstract:Bilharzial therapy has never been satisfactory, either preparations were too toxic as in the case of antimonials or relatively ineffective against one or other forms of the disease e.g. Lucanthone. With the introduction or Metriphonate it seemed as if we 'have a drug which is cheap, very effective against S. haematobium and reported to be safe. A single case is reported of apparent clinical organophosphate poisoning following an appropriate single dose of Metriphonate for the treatment of S. haematobium infestation.
Molecular Modeling of the Multiple-Substrate Activity of the Human Recombinant Intra-Melanosomal Domain of Tyrosinase and Its OCA1B-Related Mutant Variant P406L

Monika B. Dolinska,Yuri V. Sergeev

DOI: https://doi.org/10.3390/ijms25063373

IF: 5.6

2024-03-16

International Journal of Molecular Sciences

Abstract:Tyrosinase serves as the key enzyme in melanin biosynthesis, catalyzing the initial steps of the pathway, the hydroxylation of the amino acid L-tyrosine into L-3,4-dihydroxyphenylalanine (L-DOPA), followed by the subsequent oxidation of L-DOPA into dopaquinone (DQ), and it facilitates the conversion of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) into 5,6-indolequinone-2-carboxylic acid (IQCA) and 5,6-dihydroxy indole (DHI) into indolequinone (IQ). Despite its versatile substrate capabilities, the precise mechanism underlying tyrosinase's multi-substrate activity remains unclear. Previously, we expressed, purified, and characterized the recombinant intra-melanosomal domain of human tyrosinase (rTyr). Here, we demonstrate that rTyr mimics native human tyrosinase's catalytic activities in vitro and in silico. Molecular docking and molecular dynamics (MD) simulations, based on rTyr's homology model, reveal variable durability and binding preferences among tyrosinase substrates and products. Analysis of root mean square deviation (RMSD) highlights the significance of conserved residues (E203, K334, F347, and V377), which exhibit flexibility during the ligands' binding. Additionally, in silico analysis demonstrated that the OCA1B-related P406L mutation in tyrosinase substantially influences substrate binding, as evidenced by the decreased number of stable ligand conformations. This correlation underscores the mutation's impact on substrate docking, which aligns with the observed reduction in rTyr activity. Our study highlights how rTyr dynamically adjusts its structure to accommodate diverse substrates and suggests a way to modulate rTyr ligand plasticity.

biochemistry & molecular biology,chemistry, multidisciplinary
Tyr352 as a Predominant Phosphosite in the Understudied Kinase and Molecular Target, HIPK1: Implications for Cancer Therapy

Diya Sanjeev,Mejo George,Levin John,Athira Perunelly Gopalakrishnan,Pahal Priyanka,Spoorthi Mendon,Tanuja Yandigeri,Mahammad Nisar,Muhammad Nisar,Saptami Kanekar,Rex Devasahayam Arokia Balaya,Rajesh Raju

DOI: https://doi.org/10.1089/omi.2023.0244

Abstract:Homeodomain-interacting protein kinase 1 (HIPK1) is majorly found in the nucleoplasm. HIPK1 is associated with cell proliferation, tumor necrosis factor-mediated cellular apoptosis, transcription regulation, and DNA damage response, and thought to play significant roles in health and common diseases such as cancer. Despite this, HIPK1 remains an understudied molecular target. In the present study, based on a systematic screening and mapping approach, we assembled 424 qualitative and 44 quantitative phosphoproteome datasets with 15 phosphosites in HIPK1 reported across multiple studies. These HIPK1 phosphosites were not currently attributed to any functions. Among them, Tyr352 within the kinase domain was identified as the predominant phosphosite modulated in 22 differential datasets. To analyze the functional association of HIPK1 Tyr352, we first employed a stringent criterion to derive its positively and negatively correlated protein phosphosites. Subsequently, we categorized the correlated phosphosites in known interactors, known/predicted kinases, and substrates of HIPK1, for their prioritized validation. Bioinformatics analysis identified their significant association with biological processes such as the regulation of RNA splicing, DNA-templated transcription, and cellular metabolic processes. HIPK1 Tyr352 was also identified to be upregulated in Her2+ cell lines and a subset of pancreatic and cholangiocarcinoma tissues. These data and the systems biology approach undertaken in the present study serve as a platform to explore the functional role of other phosphosites in HIPK1, and by extension, inform cancer drug discovery and oncotherapy innovation. In all, this study highlights the comprehensive phosphosite map of HIPK1 kinase and the first of its kind phosphosite-centric analysis of HIPK1 kinase based on global-level phosphoproteomics datasets derived from human cellular differential experiments across distinct experimental conditions.
Kinase domain autophosphorylation rewires the activity and substrate specificity of CK1 enzymes

Sierra N. Cullati,Apirat Chaikuad,Jun-Song Chen,Jakob Gebel,Laura Tesmer,Rezart Zhubi,Jose Navarrete-Perea,Rodrigo X. Guillen,Steven P. Gygi,Gerhard Hummer,Volker Dötsch,Stefan Knapp,Kathleen L. Gould

DOI: https://doi.org/10.1016/j.molcel.2022.03.005

IF: 16

2022-03-01

Molecular Cell

Abstract:SummaryCK1s are acidophilic serine/threonine kinases with multiple critical cellular functions; their misregulation contributes to cancer, neurodegenerative diseases, and sleep phase disorders. Here, we describe an evolutionarily conserved mechanism of CK1 activity: autophosphorylation of a threonine (T220 in human CK1δ) located at the N terminus of helix αG, proximal to the substrate binding cleft. Crystal structures and molecular dynamics simulations uncovered inherent plasticity in αG that increased upon T220 autophosphorylation. The phosphorylation-induced structural changes significantly altered the conformation of the substrate binding cleft, affecting substrate specificity. In T220 phosphorylated yeast and human CK1s, activity toward many substrates was decreased, but we also identified a high-affinity substrate that was phosphorylated more rapidly, and quantitative phosphoproteomics revealed that disrupting T220 autophosphorylation rewired CK1 signaling in Schizosaccharomyces pombe. T220 is present exclusively in the CK1 family, thus its autophosphorylation may have evolved as a unique regulatory mechanism for this important family.

cell biology,biochemistry & molecular biology
Functional Profiling of Serine, Threonine and Tyrosine Sites

Yizhou Li,Tao Xu,Huazheng Ma,Di Yue,Qiezhong Lamao,Ying Liu,Zhuo Zhou,Wensheng Wei

DOI: https://doi.org/10.1038/s41589-024-01731-0

IF: 14.8

2024-01-01

Nature Chemical Biology

Abstract:Systematic perturbation of amino acids at endogenous loci provides diverse insights into protein function. Here, we performed a genome-wide screen to globally assess the cell fitness dependency of serine, threonine and tyrosine residues. Using an adenine base editor, we designed a whole-genome library comprising 817,089 single guide RNAs to perturb 584,337 S, T and Y sites. We identified 3,467 functional substitutions affecting cell fitness and 677 of them involving phosphorylation, including numerous phosphorylation-mediated gain-of-function substitutions that regulate phosphorylation levels of itself or downstream factors. Furthermore, our findings highlight that specific substitution types, notably serine to proline, are crucial for maintaining domain structure broadly. Lastly, we demonstrate that 309 enriched hits capable of initiating cell overproliferation might be potential cancer driver mutations. This study represents an extensive functional profiling of S, T and Y residues and provides insights into the distinctive roles of these amino acids in biological mechanisms and tumor progression. The use of an adenine base editor enables identification of functional serine, threonine and tyrosine residues that impact cell fitness on a genome-wide scale with possible involvement in phosphorylation, structural maintenance and cancer biology.
Genetically Encoding Phosphotyrosine and Its Nonhydrolyzable Analog in Bacteria

Xiaozhou Luo,Guangsen Fu,Rongsheng E Wang,Xueyong Zhu,Claudio Zambaldo,Renhe Liu,Tao Liu,Xiaoxuan Lyu,Jintang Du,Weimin Xuan,Anzhi Yao,Sean A Reed,Mingchao Kang,Yuhan Zhang,Hui Guo,Chunhui Huang,Peng-Yu Yang,Ian A Wilson,Peter G Schultz,Feng Wang

DOI: https://doi.org/10.1038/nchembio.2405

IF: 14.8

2017-01-01

Nature Chemical Biology

Abstract:Tyrosine phosphorylation is a common protein post-translational modification that plays a critical role in signal transduction and the regulation of many cellular processes. Using a propeptide strategy to increase cellular uptake of O-phosphotyrosine (pTyr) and its nonhydrolyzable analog 4-phosphomethyl-L-phenylalanine (Pmp), we identified an orthogonal aminoacyl-tRNA synthetase-tRNA pair that allows site-specific incorporation of both pTyr and Pmp into recombinant proteins in response to the amber stop codon in Escherichia coli in good yields. The X-ray structure of the synthetase reveals a reconfigured substrate-binding site, formed by nonconservative mutations and substantial local structural perturbations. We demonstrate the utility of this method by introducing Pmp into a putative phosphorylation site and determining the affinities of the individual variants for the substrate 3BP2. In summary, this work provides a useful recombinant tool to dissect the biological functions of tyrosine phosphorylation at specific sites in the proteome.
An Overview of the Protein Tyrosine Phosphatase Superfamily

Wei Qing Wang,Jin‐Peng Sun,Zhong-Yin Zhang

DOI: https://doi.org/10.2174/1568026033452302

2003-01-01

Current Topics in Medicinal Chemistry

Abstract:The human genome encodes approximately 100 phosphatases that belong to the protein tyrosine phosphatase (PTP) superfamily, whose substrates range from proteins to phosphoinositides and mRNAs. The hallmark for this superfamily is the active site sequence C(X)5R, also known as the PTP signature motif. The PTPs are key regulatory components in signal transduction pathways and the importance of PTPs in the control of cellular signaling is well established. Furthermore, there are compelling reasons to believe that PTP inhibitors may serve as novel medicinal agents for the treatment of various diseases. Based on structure and substrate specificity, the PTP super-family is divided into four distinct subfamilies: 1) pTyr specific PTPs, 2) dual specificity phosphatases, 3) Cdc25 phosphatases, and 4) LMW PTPs. The PTPs have similar core structures made of a central parallel β- sheet with flanking α-helices containing a β-loop-α loop that encompasses the PTP signature motif. Not surprisingly, they employ a common chemical mechanism for phosphate hydrolysis despite the differences in substrate specificity. Despite the conserved structural and catalytic properties, there are also sufficient differences in the active site pockets and its immediate surrounding environment among different PTPs. Further structural and mechanistic study will continue to be of considerable importance, providing a solid basis for inhibitor design. Keywords: Protein, Tyrosine, Phosphatase, human genome
A dynamically coupled allosteric network underlies binding cooperativity in Src kinase

Zachariah H. Foda,Yibing Shan,Eric T. Kim,David E. Shaw,Markus A. Seeliger

DOI: https://doi.org/10.1038/ncomms6939

IF: 16.6

2015-01-20

Nature Communications

Abstract:Protein tyrosine kinases are attractive drug targets because many human diseases are associated with the deregulation of kinase activity. However, how the catalytic kinase domain integrates different signals and switches from an active to an inactive conformation remains incompletely understood. Here we identify an allosteric network of dynamically coupled amino acids in Src kinase that connects regulatory sites to the ATP- and substrate-binding sites. Surprisingly, reactants (ATP and peptide substrates) bind with negative cooperativity to Src kinase while products (ADP and phosphopeptide) bind with positive cooperativity. We confirm the molecular details of the signal relay through the allosteric network by biochemical studies. Experiments on two additional protein tyrosine kinases indicate that the allosteric network may be largely conserved among these enzymes. Our work provides new insights into the regulation of protein tyrosine kinases and establishes a potential conduit by which resistance mutations to ATP-competitive kinase inhibitors can affect their activity.

multidisciplinary sciences
Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways

Yu Zhou,Xin Li,Ru Shen,Xiangzhu Wang,Fan Zhang,Suxing Liu,Di Li,Jian Liu,Puhui Li,Yinfa Yan,Ping Dong,Zhigao Zhang,Heping Wu,Linghang Zhuang,Rasheduzzaman Chowdhury,Matthew Miller,Mena Issa,Yuchang Mao,Hongli Chen,Jun Feng,Jing Li,Chang Bai,Feng He,Weikang Tao

DOI: https://doi.org/10.3389/fimmu.2022.884399

2022-05-20

Abstract:A member of the Janus kinase (JAK) family, Tyrosine Kinase 2 (TYK2), is crucial in mediating various cytokine-signaling pathways such as interleukin-23 (IL23), interleukin-12 (IL12) and type I Interferons (IFN) which contribute to autoimmune disorders (e.g., psoriasis, lupus, and inflammatory bowel disease). Thus, TYK2 represents an attractive target to develop small-molecule therapeutics for the treatment of cytokine-driven inflammatory diseases. Selective inhibition of TYK2 over other JAK isoforms is critical to achieve a favorable therapeutic index in the development of TYK2 inhibitors. However, designing small molecule inhibitors to target the adenosine triphosphate (ATP) binding site of TYK2 kinase has been challenging due to the substantial structural homology of the JAK family catalytic domains. Here, we employed an approach to target the JAK homology 2 (JH2) pseudokinase regulatory domain of the TYK2 protein. We developed a series of small-molecule TYK2 pseudokinase ligands, which suppress the TYK2 catalytic activity through allosteric regulation. The TYK2 pseudokinase-binding small molecules in this study simultaneously achieve high affinity-binding for the TYK2 JH2 domain while also affording significantly reduced affinity for the TYK2 JAK homology 1 (JH1) kinase domain. These TYK2 JH2 selective molecules, although possessing little effect on suppressing the catalytic activity of the isolated TYK2 JH1 catalytic domain in the kinase assays, can still significantly block the TYK2-mediated receptor-stimulated pathways by binding to the TYK2 JH2 domain and allosterically regulating the TYK2 JH1 kinase. These compounds are potent towards human T-cell lines and primary immune cells as well as in human whole-blood specimens. Moreover, TYK2 JH2-binding ligands exhibit remarkable selectivity of TYK2 over JAK isoforms not only biochemically but also in a panel of receptor-stimulated JAK1/JAK2/JAK3-driven cellular functional assays. In addition, the TYK2 JH2-targeting ligands also demonstrate high selectivity in a multi-kinase screening panel. The data in the current study underscores that the TYK2 JH2 pseudokinase is a promising therapeutic target for achieving a high degree of biological selectivity. Meanwhile, targeting the JH2 domain represents an appealing strategy for the development of clinically well-tolerated TYK2 inhibitors that would have superior efficacy and a favorable safety profile compared to the existing Janus kinase inhibitors against autoimmune diseases.
[Centro-peripheral etiopathogenesis of primary headache triggered nasally].

F. Ottaviani

Abstract:The presence of endonasal pathological conditions or headache accompanying symptoms involving the nose, show a bi-directional link between the latter and endocranial structures. Instrumental diagnostic procedures allow demonstration of anatomical variants of the bone. Frequently, surgical procedures addressed to correct such variants seem to resolve both headache and breathing disturbances. However, hyperactivity of nasal mucosa and microcirculation might be responsible for cephalic disturbance as a consequence of activation of neuro-vascular systems (trigeminal, sympathetic, parasympathetic) and explain both pain and attendant accompanying symptoms during migraine and cluster headache attacks. Peripheral triggering or aggravating factors may, therefore, be responsible for or, at least, contribute to pathophysiological mechanisms of certain headaches.
Evolutionary sequence and structural basis for the distinct conformational landscapes of Tyr and Ser/Thr kinases

Joan Gizzio,Abhishek Thakur,Allan Haldane,Carol Beth Post,Ronald M. Levy

DOI: https://doi.org/10.1101/2024.03.08.584161

2024-05-02

Abstract:Protein kinases are molecular machines with rich sequence variation that distinguishes the two main evolutionary branches – tyrosine kinases (TKs) from serine/threonine kinases (STKs). Using a sequence co-variation Potts statistical energy model we previously concluded that TK catalytic domains are more likely than STKs to adopt an inactive conformation with the activation loop in an autoinhibitory “folded” conformation, due to intrinsic sequence effects. Here we investigated the structural basis for this phenomenon by integrating the sequence-based model with structure-based molecular dynamics (MD) to determine the effects of mutations on the free energy difference between active and inactive conformations, using a novel thermodynamic cycle involving many (n=108) protein-mutation free energy perturbation (FEP) simulations in the active and inactive conformations. The sequence and structure-based results are consistent and support the hypothesis that the inactive conformation “DFG-out Activation Loop Folded”, is a functional regulatory state that has been stabilized in TKs relative to STKs over the course of their evolution via the accumulation of residue substitutions in the activation loop and catalytic loop that facilitate distinct substrate binding modes and additional modes of regulation for TKs.

Biophysics
Phosphopredict: A Bioinformatics Tool for Prediction of Human Kinase-Specific Phosphorylation Substrates and Sites by Integrating Heterogeneous Feature Selection

Jiangning Song,Huilin Wang,Jiawei Wang,André Leier,Tatiana Marquez-Lago,Bingjiao Yang,Ziding Zhang,Tatsuya Akutsu,Geoffrey I. Webb,Roger J. Daly

DOI: https://doi.org/10.1038/s41598-017-07199-4

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Protein phosphorylation is a major form of post-translational modification (PTM) that regulates diverse cellular processes. In silico methods for phosphorylation site prediction can provide a useful and complementary strategy for complete phosphoproteome annotation. Here, we present a novel bioinformatics tool, PhosphoPredict, that combines protein sequence and functional features to predict kinase-specific substrates and their associated phosphorylation sites for 12 human kinases and kinase families, including ATM, CDKs, GSK-3, MAPKs, PKA, PKB, PKC, and SRC. To elucidate critical determinants, we identified feature subsets that were most informative and relevant for predicting substrate specificity for each individual kinase family. Extensive benchmarking experiments based on both five-fold cross-validation and independent tests indicated that the performance of PhosphoPredict is competitive with that of several other popular prediction tools, including KinasePhos, PPSP, GPS, and Musite. We found that combining protein functional and sequence features significantly improves phosphorylation site prediction performance across all kinases. Application of PhosphoPredict to the entire human proteome identified 150 to 800 potential phosphorylation substrates for each of the 12 kinases or kinase families. PhosphoPredict significantly extends the bioinformatics portfolio for kinase function analysis and will facilitate high-throughput identification of kinase-specific phosphorylation sites, thereby contributing to both basic and translational research programs.
Controlling Kinase Activities by Selective Inhibition of Peptide Substrates

Xiaowei Li,Tania M. Palhano Zanela,Eric S. Underbakke,Yan Zhao

DOI: https://doi.org/10.1021/jacs.0c11566

IF: 15

2021-01-04

Journal of the American Chemical Society

Abstract:Phosphorylation is the most common reversible post-translational modification (PTM) of proteins. Because a given kinase often has many substrates in a cell and is involved in numerous functions, traditional inhibition of the enzyme leads to unintended consequences. Here we report synthetic receptors to manipulate kinase phosphorylation precisely for the first time, utilizing the receptors' abilities to bind peptides with high affinity and specificity. The inhibition enables selective phosphorylation of peptides with identical consensus motifs in a mixture. A particular phosphosite can be inhibited while other sites in the same substrate undergo phosphorylation. The receptors may work either individually on their targeted strands or in concert to protect segments of a long sequence. The binding-derived inhibition is able to compete with protein–protein interactions within a multidomain kinase, enabling controlled PTM to be performed in a previously unavailable manner.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c11566?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c11566</a>.Synthetic, protein purification, and assay procedures, chromatographs, and NMR data (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c11566/suppl_file/ja0c11566_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

chemistry, multidisciplinary
Pituitary Surgery for Cushing’s Disease

M. Buchfelder,S. Schlaffer

DOI: https://doi.org/10.1159/000314223

2010-09-01

Neuroendocrinology

Abstract:In this article, the present status of neurosurgical operations for Cushing’s disease is briefly reviewed. Transsphenoidal surgery is considered the treatment of choice in most patients with Cushing’s disease once the diagnosis has been established. In a considerable proportion of patients, even sophisticated imaging does not directly depict the tiny microadenoma. The search for the tumor is technically difficult, particularly when the sella turcica is small, the dura vascularized and the sphenoid sinus poorly pneumatized. Thus, even in expert hands, microadenomas cannot always be identified intraoperatively. Usually, a selective adenomectomy is attempted, preserving pituitary functions. There is a huge variation of surgical outcomes reported. As an estimate, a remission rate of some 75% can be expected 5 years after surgery. Almost all data available to date derive from microsurgical operations. Unfortunately, even in patients who initially remit, recurrences may occur. Low postoperative serum cortisol levels and a long-lasting adrenocortical insufficiency seem to be factors associated with a favorable long-term outcome. When no distinct microadenoma can be identified intraoperatively, partial or even total hypophysectomy has been suggested. However, the outcome of these procedures is less favorable than with selective resections of distinct adenomas. Less than 10% of pituitary adenomas associated with Cushing’s disease are macroadenomas. These also bear a less favorable outcome than microadenomas. Only for selected patients with mainly extrasellar tumor localizations are craniotomies recommended. A close cooperation with the endocrinologist is mandatory for a neurosurgeon operating on patients with Cushing’s disease, namely for the pre- and perioperative care and for long-term follow-up.
Proteasome regulation by reversible tyrosine phosphorylation at the membrane

Lu Chen,Yanan Zhang,Xin Shu,Qiong Chen,Tiantian Wei,Heman Wang,Xiaorong Wang,Qirou Wu,Xiaomei Zhang,Xiaoyan Liu,Suya Zheng,Lan Huang,Junyu Xiao,Chao Jiang,Bing Yang,Zhiping Wang,Xing Guo

DOI: https://doi.org/10.1038/s41388-021-01674-z

IF: 8.756

2021-02-18

Oncogene

Abstract:Reversible phosphorylation has emerged as an important mechanism for regulating 26S proteasome function in health and disease. Over 100 phospho-tyrosine sites of the human proteasome have been detected, and yet their function and regulation remain poorly understood. Here we show that the 19S subunit Rpt2 is phosphorylated at Tyr439, a strictly conserved residue within the C-terminal HbYX motif of Rpt2 that is essential for 26S proteasome assembly. Unexpectedly, we found that Y439 phosphorylation depends on Rpt2 membrane localization mediated by its N-myristoylation. Multiple receptors tyrosine kinases can trigger Rpt2–Y439 phosphorylation by activating Src, a N-myristoylated tyrosine kinase. Src directly phosphorylates Rpt2–Y439 in vitro and negatively regulates 26S proteasome activity at cellular membranes, which can be reversed by the membrane-associated isoform of protein tyrosine phosphatase nonreceptor type 2 (PTPN2). In H1975 lung cancer cells with activated Src, blocking Rpt2–Y439 phosphorylation by the Y439F mutation conferred partial resistance to the Src inhibitor saracatinib both in vitro and in a mouse xenograft tumor model, and caused significant changes of cellular responses to saracatinib at the proteome level. Our study has defined a novel mechanism involved in the spatial regulation of proteasome function and provided new insights into tyrosine kinase inhibitor-based anticancer therapies.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology

[Extraneural metastases of gliomas (author's transl)].

An atlas of substrate specificities for the human serine/threonine kinome

Switching of the Substrate Specificity of Protein Tyrosine Phosphatase N12 by Cyclin‐dependent Kinase 2 Phosphorylation Orchestrating 2 Oncogenic Pathways

High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display

Site-specific Proteasome Phosphorylation Controls Cell Proliferation and Tumorigenesis

One-Step SH2 Superbinder-Based Approach for Sensitive Analysis of Tyrosine Phosphoproteome.

Metriphonate and organophosphate poisoning.

Molecular Modeling of the Multiple-Substrate Activity of the Human Recombinant Intra-Melanosomal Domain of Tyrosinase and Its OCA1B-Related Mutant Variant P406L

Tyr352 as a Predominant Phosphosite in the Understudied Kinase and Molecular Target, HIPK1: Implications for Cancer Therapy

Kinase domain autophosphorylation rewires the activity and substrate specificity of CK1 enzymes

Functional Profiling of Serine, Threonine and Tyrosine Sites

Genetically Encoding Phosphotyrosine and Its Nonhydrolyzable Analog in Bacteria

An Overview of the Protein Tyrosine Phosphatase Superfamily

A dynamically coupled allosteric network underlies binding cooperativity in Src kinase

Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways

[Centro-peripheral etiopathogenesis of primary headache triggered nasally].

Evolutionary sequence and structural basis for the distinct conformational landscapes of Tyr and Ser/Thr kinases

Phosphopredict: A Bioinformatics Tool for Prediction of Human Kinase-Specific Phosphorylation Substrates and Sites by Integrating Heterogeneous Feature Selection

Controlling Kinase Activities by Selective Inhibition of Peptide Substrates

Pituitary Surgery for Cushing’s Disease

Proteasome regulation by reversible tyrosine phosphorylation at the membrane